All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
LevFinLevFin Leveraged Loans

AMCo moves debt into amortising tranche and reduces loan size

Amdipharm Mercury, the UK generic pharmaceuticals company, has reduced the size of its £984m refinancing and recapitalisation loan and split the debt into amortising and bullet tranches.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree